Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
vancomycin	O
/	O
bacitracin	O
/	O
morphone	O
/	O
clindamycin	O
Attending:	O
___	O
Chief	O
Complaint:	O
shortness	O
of	O
breath,	O
atrial	O
fibrillation	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
none	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
F	O
with	O
history	O
of	O
COPD/asthma	O
(2L	O
NC	O
at	O
home),	O
breast	O
cancer	O
(s/p	O
mastectomy),	O
pAF/tachybrady	O
syndrome	O
with	O
recent	O
PPM	O
placement	O
c/b	O
RV	O
perforation	O
with	O
pericardial	O
effusion,	O
Afib	O
with	O
RVR,	O
recent	O
HCAP	B-Lower_respiratory_tract_infection
tx	O
with	O
Levofloxacin	O
who	O
presents	O
with	O
progressive	O
SOB,	O
sputum	O
production,	O
chills	O
and	O
recurrent	O
atrial	O
fibrillation	O
with	O
RVR.	O
In	O
brief,	O
patient	O
was	O
in	O
usual	O
state	O
of	O
health	O
when	O
she	O
developed	O
an	O
episode	O
of	O
chest	O
discomfort	O
and	O
unresponsiveness	O
x	O
10	O
seconds	O
with	O
shaking	O
of	O
her	O
extremities	O
at	O
home	O
and	O
was	O
admitted	O
to	O
___	O
___.	O
Had	O
DDD	O
___	O
pacemaker	O
implanted	O
___	O
for	O
SSS	O
w/HR	O
___	O
and	O
3.3	O
sec	O
pauses.	O
Subsequently	O
developed	O
___	O
chest	O
pain	O
and	O
Chest	O
CT	O
showed	O
RV	O
pacemaker	O
lead	O
extends	O
2	O
cm	O
below	O
the	O
RV	O
wall,	O
tip	O
lying	O
in	O
the	O
pericardial	O
fat	O
pad	O
just	O
behind	O
the	O
left	O
anterior	O
lateral	O
sixth	O
rib.	O
TTE	O
showed	O
pericardial	O
effusion	O
without	O
tamponade.	O
She	O
was	O
transferred	O
to	O
___	O
for	O
further	O
monitoring.	O
She	O
underwent	O
lead	O
extraction	O
in	O
the	O
OR	O
on	O
___	O
and	O
was	O
persistently	O
hypotensive	O
afterwards	O
requiring	O
intubation	O
and	O
pressors.	O
In	O
this	O
setting	O
she	O
developed	O
a	O
transaminitis	O
that	O
was	O
thought	O
to	O
be	O
secondary	O
to	O
hypotension.	O
Her	O
pericardial	O
effusion	O
remained	O
minimal	O
and	O
she	O
was	O
restarted	O
on	O
apixaban	O
prior	O
to	O
discharge.	O
Her	O
course	O
was	O
otherwise	O
complicated	O
by	O
recurrent	O
afib	O
with	O
RVR,	O
which	O
was	O
initially	O
treated	O
with	O
DCCV	O
and	O
sotalol	O
but	O
she	O
was	O
subsequently	O
transitioned	O
to	O
metoprolol	O
for	O
rate	O
control.	O
Finally	O
she	O
was	O
noted	O
to	O
have	O
a	O
positive	O
UA	O
and	O
productive	O
cough	O
and	O
so	O
was	O
treated	O
for	O
HCAP	B-Lower_respiratory_tract_infection
UTI	B-Urinary_tract_infection
with	O
levofloxacin.	O
She	O
was	O
discharged	O
on	O
___	O
to	O
rehab.	O
At	O
rehab	O
she	O
reports	O
that	O
she	O
has	O
been	O
feeling	O
unwell.	O
She	O
feels	O
that	O
her	O
breathing	O
has	O
worsened	O
and	O
she	O
is	O
more	O
SOB	O
than	O
her	O
normal	O
baseline.	O
She	O
reports	O
that	O
she	O
has	O
had	O
worsening	O
chills	O
but	O
no	O
fevers	O
and	O
has	O
had	O
worsening	O
cough	O
with	O
sputum	O
production.	O
Finally	O
she	O
notes	O
that	O
she	O
has	O
had	O
worsening	O
lower	O
extremity	O
swelling	O
and	O
was	O
started	O
on	O
Lasix	O
at	O
rehab	O
without	O
significant	O
improvement.	O
She	O
states	O
that	O
in	O
this	O
setting	O
she	O
developed	O
increased	O
fatigue	O
and	O
SOB	O
on	O
morning	O
of	O
admission.	O
This	O
prompted	O
an	O
EKG,	O
which	O
showed	O
a	O
fib	O
w/	O
RVR.	O
This	O
prompted	O
her	O
transport	O
to	O
___.	O
She	O
was	O
taken	O
to	O
___	O
where	O
intial	O
vitals	O
were	O
99.4	O
89	O
131/65	O
18	O
94RA.	O
She	O
was	O
ill	O
appearing	O
per	O
their	O
documentations.	O
Labs	O
were	O
notable	O
for	O
Tnt	O
<0.01,	O
WBC	O
16.8	O
(89%	O
N),	O
Hgb	O
12.2.	O
proBNP	O
2463.	O
CXR	O
showed	O
left	O
lower	O
lobe	O
consolidation	O
with	O
associated	O
effusion.	O
Given	O
recent	O
admission	O
to	O
___	O
she	O
was	O
transferred	O
for	O
further	O
care.	O
No	O
medications	O
were	O
given.	O
In	O
the	O
ED	O
initial	O
vitals	O
were:	O
99.1	O
88	O
130/66	O
96%	O
NC	O
EKG:	O
NSR	O
@	O
87bpm.	O
NA,	O
Qtc	O
530,	O
low	O
limb	O
volts.	O
No	O
ischemic	O
changes.	O
Physical	O
exam	O
notable	O
for:	O
pitting	O
edema,	O
and	O
decreased	O
breath	O
sounds.	O
Labs/studies	O
notable	O
for:	O
WBC	O
16.5,	O
Hgb	O
11.7.	O
proBNP:	O
2629,	O
Trop	O
negative.	O
UA	O
bland.	O
Bilateral	O
LENIs	O
negative	O
for	O
DVT,	O
LUENI	O
with	O
no	O
clot	O
but	O
phlebitis.	O
Patient	O
was	O
given:	O
IV	O
Piperacillin-Tazobactam	O
4.5	O
g	O
Vitals	O
on	O
transfer:	O
99.1	O
86	O
20	O
140/70	O
95%	O
2LNC	O
On	O
arrival	O
to	O
the	O
floor,	O
patient	O
reports	O
that	O
she	O
feels	O
fatigued	O
from	O
the	O
days	O
activities	O
but	O
does	O
not	O
have	O
any	O
specific	O
complaints	O
other	O
than	O
chills	O
and	O
LUE	O
arms	O
swelling.	O
She	O
endorses	O
cough	O
as	O
above,	O
DOE,	O
PND,	O
chest	O
pain.	O
No	O
abdominal	O
pain,	O
nausea,	O
vomiting,	O
diarrhea.	O
+	O
Mild	O
constipation.	B-Constipation
No	O
dysuria.	O
REVIEW	O
OF	O
SYSTEMS:	O
(+)	O
per	O
HPI	O
Past	O
Medical	O
History:	O
1.	O
CARDIAC	O
RISK	O
FACTORS	O
-	O
Dyslipidemia	O
2.	O
CARDIAC	O
HISTORY	O
-	O
Coronaries:	O
Unknown,	O
no	O
h/o	O
CAD/MI	O
-	O
Pump:	O
EF	O
>	O
55%	O
-	O
Rhythm:	O
NSR,	O
PAF/tachy-brady	O
Back	O
up	O
pacing.	O
On	O
apixaban	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY	O
-	O
Breast	O
cancer	O
-	O
Skin	O
cancer,	O
squamous	O
cell	O
-	O
Gastroesophageal	O
reflux	O
disease	O
-	O
Herpes	O
zoster	O
-	O
Diverticulitis	O
-	O
Sinusitis	O
-	O
Lung	O
nodules	O
-	O
History	O
of	O
C	O
diff	O
colitis	O
-	O
Chronic	O
obstructive	O
pulmonary	O
disease,	O
severe	O
-	O
Asthma	O
-	O
Bilateral	O
cataracts	B-Visual_impairment
-	O
Hyperlipidemia	O
-	O
Osteoarthritis	O
Social	O
History:	O
___	O
Family	O
History:	O
No	O
family	O
history	O
of	O
early	O
MI,	O
arrhythmia,	O
cardiomyopathies,	O
or	O
sudden	O
cardiac	O
death.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
VS:	O
97.7	O
PO	O
132	O
/	O
93	O
87	O
18	O
96	O
3L	O
Admission	O
Wt	O
69.2kg/152.56lb	O
from	O
63.5kg/140lb	O
on	O
___	O
GENERAL:	O
Well	O
appearing.	O
Speaking	O
in	O
full	O
sentences.	O
HEENT:	O
OP	O
clear,	O
MMM.	O
NECK:	O
JVP	O
not	O
appreciated	O
at	O
90,	O
45,	O
15	O
degrees	O
CARDIAC:	O
+	O
Triphasic	O
rub.	O
Distant	O
heart	O
sounds	O
but	O
regular	O
with	O
normal	O
S1,S2	O
with	O
no	O
appreciated	O
m/r/g.	O
Pulsus	O
10.	O
LUNG:	O
Decreased	O
breath	O
sounds	O
at	O
L	O
base	O
with	O
associated	O
dullness	O
to	O
percussion	O
and	O
decreased	O
fremitus.	O
Otherwise	O
no	O
w/r/r	O
ABDOMEN:	O
Soft,	O
NT,	O
ND.	O
Liver	O
without	O
palpable	O
pulsatiity.	O
NABS	O
EXTREMITIES:	O
2+	O
___	O
edema	O
to	O
knee,	O
1+	O
edema	O
to	O
sacrum.	O
LUE	O
with	O
swelling,	O
no	O
edema.	O
RUE	O
with	O
diffuse	O
echhymosis.	O
PULSES:	O
2+	O
NEURO:	O
Pleasant,	O
non-focal.	O
Normal	B-Delirium
mentation.	B-Delirium
PHYSICAL	O
EXAM	O
ON	O
DISCHARGE	O
VS:	O
T	O
98,	O
113-117/56-66,	O
HR	O
79-80,	O
RR	O
18,	O
O2	O
sat	O
99%	O
2L	O
NC	O
wt	O
65.0	O
kg	O
GENERAL:	O
WNWND	O
female,	O
appears	O
tired	O
but	O
responding	O
appropriately	O
HEENT:	O
JVP	O
~7	O
cm	O
when	O
assessed	O
at	O
upright	O
CV:	O
RRR,	O
+pericardial	O
friction	O
rub	O
Lungs:	O
faint	O
basilar	O
crackles	O
appreciated	O
posteriorly	O
on	O
L	O
Abd:	O
soft,	O
NTND	O
Extrem:	O
2+	O
pitting	O
edema	O
to	O
ankle;	O
2+	O
___	O
pulses	O
b/l	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
================	O
___	O
06:00PM	O
BLOOD	O
WBC-16.5*	O
RBC-4.02	O
Hgb-11.7	O
Hct-38.2	O
MCV-95	O
MCH-29.1	O
MCHC-30.6*	O
RDW-13.4	O
RDWSD-46.9*	O
Plt	O
___	O
___	O
06:00PM	O
BLOOD	O
Glucose-90	O
UreaN-9	O
Creat-0.7	O
Na-141	O
K-3.7	O
Cl-101	O
HCO3-26	O
AnGap-18	O
___	O
06:00PM	O
BLOOD	O
Calcium-8.2*	O
Phos-3.5	O
Mg-1.9	O
PERTINENT	O
LABS	O
================	O
___	O
06:00PM	O
BLOOD	O
proBNP-2629*	O
___	O
06:00PM	O
BLOOD	O
cTropnT-<0.01	O
___	O
06:50AM	O
BLOOD	O
cTropnT-<0.01	O
___	O
06:50AM	O
BLOOD	O
ALT-52*	O
AST-26	O
AlkPhos-69	O
TotBili-1.1	O
___	O
04:38PM	O
BLOOD	O
Type-ART	O
pO2-82*	O
pCO2-38	O
pH-7.46*	O
calTCO2-28	O
Base	O
XS-2	O
___	O
07:15AM	O
BLOOD	O
WBC-17.2*	O
RBC-3.97	O
Hgb-11.8	O
Hct-38.1	O
MCV-96	O
MCH-29.7	O
MCHC-31.0*	O
RDW-13.8	O
RDWSD-48.6*	O
Plt	O
___	O
___	O
07:15AM	O
BLOOD	O
Glucose-81	O
UreaN-10	O
Creat-0.7	O
Na-140	O
K-4.1	O
Cl-102	O
HCO3-27	O
AnGap-15	O
___	O
07:15AM	O
BLOOD	O
Calcium-8.6	O
Phos-3.1	O
Mg-2.2	O
___	O
04:38PM	O
BLOOD	O
Type-ART	O
pO2-82*	O
pCO2-38	O
pH-7.46*	O
calTCO2-28	O
Base	O
XS-2	O
___	O
Cardiovascular	O
ECHO	O
Conclusions	O
The	O
left	O
atrium	O
is	O
normal	O
in	O
size.	O
No	O
atrial	O
septal	O
defect	O
is	O
seen	O
by	O
2D	O
or	O
color	O
Doppler.	O
Left	O
ventricular	O
wall	O
thickness,	O
cavity	O
size	O
and	O
regional/global	O
systolic	O
function	O
are	O
normal	O
(LVEF	O
>55%).	O
There	O
is	O
no	O
ventricular	O
septal	O
defect.	O
with	O
normal	O
free	O
wall	O
contractility.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
but	O
aortic	O
stenosis	O
is	O
not	O
present.	O
No	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	O
regurgitation.	O
The	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
a	O
small	O
pericardial	O
effusion.	O
There	O
are	O
no	O
echocardiographic	O
signs	O
of	O
tamponade.	O
Compared	O
with	O
the	O
prior	O
study	O
(images	O
reviewed)	O
of	O
___,	O
the	O
pericardial	O
effusion	O
is	O
slightly	O
larger.	O
___	O
Imaging	O
CHEST	O
(PA	O
&	O
LAT)	O
IMPRESSION:	O
Comparison	O
to	O
___.	O
Stable	O
appearance	O
of	O
the	O
known	O
left	O
pleural	O
effusion	O
with	O
subsequent	O
atelectasis.	O
Stable	O
mild	O
atelectasis	O
at	O
the	O
right	O
lung	O
basis.	O
No	O
new	O
parenchymal	O
opacities	O
or	O
other	O
abnormalities	O
are	O
noted	O
in	O
the	O
right	O
hemi	O
thorax.	O
Mild	O
cardiomegaly	O
persists.	O
Stable	O
position	O
of	O
the	O
left	O
pectoral	O
pacemaker.	O
CT	O
Chest	O
with	O
Contrast	O
___:	O
1.	O
Small	O
pleural	O
effusions,	O
no	O
evidence	O
of	O
empyema.	O
New	O
small	O
opacification	O
at	O
the	O
right	O
base	O
may	O
represent	O
pneumonia.	B-Lower_respiratory_tract_infection
Mild	O
mucous	O
plugging	O
right	O
lower	O
lobe.	O
2.	O
Worsened	O
pericardial	O
effusion	O
which	O
is	O
now	O
moderate,	O
with	O
complex	O
components,	O
can	O
be	O
seen	O
with	O
hemorrhagic,	O
inflammatory/infectious	O
pericarditis.	O
3.	O
Pulmonary	O
nodules,	O
measuring	O
up	O
to	O
4	O
mm.	O
If	O
there	O
is	O
a	O
history	O
of	O
smoking	O
or	O
other	O
risk	O
factor	O
for	O
primary	O
lung	O
malignancy,	O
a	O
___	O
year	O
follow-up	O
low-dose,	O
noncontrast	O
chest	O
CT	O
is	O
recommended.	O
4.	O
A	O
0.6	O
cm	O
splenic	O
artery	O
aneurysm.	O
TTE	O
___:	O
This	O
study	O
was	O
compared	O
to	O
the	O
prior	O
study	O
of	O
___.	O
LEFT	O
VENTRICLE:	O
Overall	O
normal	O
LVEF	O
(>55%).	O
RIGHT	O
VENTRICLE:	O
Normal	O
RV	O
systolic	O
function.	O
PERICARDIUM:	O
Small	O
pericardial	O
effusion.	O
Effusion	O
circumferential.	O
Effusion	O
echo	O
dense,	O
c/w	O
blood,	O
inflammation	O
or	O
other	O
cellular	O
elements.	O
No	O
echocardiographic	O
signs	O
of	O
tamponade.	O
Brief	O
Hospital	O
Course:	O
___	O
yo	O
F	O
with	O
history	O
of	O
COPD/asthma	O
(2L	O
NC	O
at	O
home),	O
pAF/tachybrady	O
syndrome	O
with	O
recent	O
PPM	O
placement	O
___	O
c/b	O
RV	O
perforation	O
with	O
pericardial	O
effusion,	O
Afib	O
with	O
RVR,	O
recent	O
HCAP	B-Lower_respiratory_tract_infection
tx	O
with	O
Levofloxacin	O
who	O
presented	O
with	O
progressive	O
SOB	O
and	O
recurrent	O
atrial	O
fibrillation	O
with	O
RVR.	O
ACTIVE	O
ISSUES	O
============	O
#	O
Dyspnea:	O
Thought	O
to	O
be	O
multifactorial	O
and	O
primarily	O
driven	O
by	O
CHF	O
symptoms	O
in	O
addition	O
to	O
pericarditis,	O
pleural	O
effusion	O
and	O
possible	O
underlying	O
pneumonia.	B-Lower_respiratory_tract_infection
#	O
New	O
Onset	O
Diastolic	O
Heart	O
Failure	O
Exacerbation:	O
69.1	O
kg	O
on	O
admission	O
and	O
req	O
2L	O
NC	O
during	O
day.	O
Her	O
respiratory	O
status	O
improved	O
after	O
diuresing	O
4.7L	O
during	O
this	O
hospital	O
stay.	O
Initially	O
used	O
BID	O
Lasix	O
40	O
mg	O
IV	O
but	O
transitioned	O
to	O
20	O
mg	O
torsemide	O
PO	O
daily.	O
Please	O
titrate	O
this	O
dose	O
as	O
necessary;	O
estimated	O
dry	O
weight	O
64.5	O
kg.	O
Please	O
recheck	O
electrolytes	O
on	O
___	O
and	O
consider	O
daily	O
repletion	O
if	O
necessary.	O
#	O
Acute	O
Pericarditis:	O
surrounding	O
small	O
pericardial	O
effusion	O
seen	O
on	O
TTE.	O
Thought	O
to	O
be	O
___	O
to	O
recent	O
pericardial	O
procedures.	O
She	O
was	O
started	O
on	O
colchicine	O
0.6	O
BID	O
and	O
planned	O
to	O
treated	O
for	O
3	O
months	O
(until	O
___.	O
Aspirin	O
and	O
NSAIDs	O
were	O
deferred.	O
Received	O
TTE	O
on	O
___	O
that	O
showed	O
small	O
pericardial	O
effusion	O
stable	O
from	O
___.	O
#	O
Chest	O
Pain,	O
Musculoskeletal:	O
Pleuritic	O
but	O
less	O
concern	O
for	O
PE	O
as	O
ABG	O
normal	O
and	O
on	O
apixaban.	O
Responded	O
well	O
to	O
Tylenol.	O
#	O
Paroxysmal	O
Atrial	O
Fibrillation:	O
Patient	O
with	O
known	O
history	O
of	O
pAF	O
and	O
tachybrady	O
syndrome	O
s/p	O
PPM	O
and	O
DCCV.	O
continued	O
apixaban	O
5	O
BID	O
and	O
incresaed	O
metoprolol	O
succinate	O
to	O
150	O
AM	O
and	O
50	O
pm.	O
#	O
Health-care	B-Lower_respiratory_tract_infection
Associated	B-Lower_respiratory_tract_infection
Pneumonia:	B-Lower_respiratory_tract_infection
lack	O
of	O
improvement	O
with	O
levofloxacin.	O
Coverage	O
broadened	O
to	O
linezolid	O
___,	O
dc'd	O
after	O
negative	O
MRSA	O
swab)	O
and	O
Zosyn	O
(___).	O
CT	O
on	O
___	O
was	O
negative	O
for	O
empyema.	O
#	O
Diarrhea:	O
Thought	O
to	O
be	O
due	O
to	O
pt's	O
bowel	O
regimen	O
and	O
lactose	O
intolerance;	O
may	O
have	O
been	O
aggravated	O
by	O
antibiotics.	O
C	O
diff	O
negative.	O
CHRONIC	O
ISSUES:	O
========================	O
#	O
HLD	O
(chronic):	O
Stable,	O
treated	O
at	O
home.	O
Continued	O
atorvastatin	O
#	O
GERD	O
(chronic):	O
PO	O
PPI,	O
on	O
esomeprazole	O
at	O
home	O
(non-formulary).	O
switched	O
to	O
Omeprazole	O
while	O
inpatient	O
#	O
COPD/Asthma:	O
On	O
2LNC	O
at	O
home	O
as	O
well	O
as	O
tiotropium	O
1	O
capsule	O
qd,	O
montelukast	O
10	O
mg	O
qd,	O
and	O
fluticasone	O
500-Salmeterol	O
l50	O
1	O
puff	O
BID,	O
and	O
albuterol	O
2.5	O
mg	O
INH	O
BID.	O
continued	O
home	O
meds	O
and	O
encouraged	O
IS.	O
TRANSITIONAL	O
ISSUES	O
==================	O
***medication	O
changes***	O
-added	O
torsemide	O
20	O
mg	O
daily	O
-increased	O
metoprolol	O
succinate	O
to	O
150	O
mg	O
QAM	O
and	O
50	O
mg	O
QPM	O
-added	O
colchicine	O
0.6	O
mg	O
BID	O
FOLLOW	O
UP:	O
[	O
]	O
Please	O
repeat	O
chem-10	O
on	O
___	O
--	O
please	O
replete	O
potassium	O
for	O
goal	O
of	O
4.0;	O
may	O
need	O
daily	O
potassium	O
repletion	O
[	O
]	O
f/u	O
Cardiology	O
within	O
2	O
weeks	O
for	O
heart	O
failure,	O
pericarditis	O
atrial	O
fibrillation	O
[	O
]	O
continue	O
colchicine	O
for	O
3	O
months	O
(end	O
date	O
___	O
[	O
]	O
f/u	O
in	O
___	O
clinic	O
for	O
pacemaker	O
[	O
]	O
titrate	O
torsemide	O
dosing	O
to	O
weight	O
[	O
]	O
patient	O
noted	O
to	O
have	O
moderate	O
pulmonary	O
hypertension	O
on	O
TTE.	O
Please	O
reevaluate.	O
[	O
]	O
Pulmonary	O
nodules,	O
measuring	O
up	O
to	O
4	O
mm.	O
If	O
there	O
is	O
a	O
history	O
of	O
smoking	O
or	O
other	O
risk	O
factor	O
for	O
primary	O
lung	O
malignancy,	O
a	O
___	O
year	O
follow-up	O
low-dose,	O
noncontrast	O
chest	O
CT	O
is	O
recommended.	O
[	O
]	O
0.6	O
cm	O
splenic	O
artery	O
aneurysm	O
seen	O
on	O
CT	O
___	O
DISCHARGE	O
WEIGHT:	O
65.0	O
kg	O
standing	O
DISCHARGE	O
CR:	O
0.9	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Apixaban	O
5	O
mg	O
PO	O
BID	O
2.	O
DICYCLOMine	O
10	O
mg	O
PO	O
BID	O
3.	O
Montelukast	O
10	O
mg	O
PO	O
DAILY	O
4.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
5.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q6H:PRN	O
wheeze	O
6.	O
Atorvastatin	O
20	O
mg	O
PO	O
QPM	O
7.	O
esomeprazole	O
magnesium	O
40	O
mg	O
oral	O
DAILY	O
8.	O
fluticasone-salmeterol	O
500	O
mcg/100	O
mcg	O
inh	O
INHALATION	O
BID	O
9.	O
Levofloxacin	O
750	O
mg	O
PO	O
DAILY	O
10.	O
Metoprolol	O
Succinate	O
XL	O
150	O
mg	O
PO	O
DAILY	O
11.	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Calcium	O
Carbonate	O
500	O
mg	O
PO	O
QID:PRN	O
indigestion	O
2.	O
Colchicine	O
0.6	O
mg	O
PO	O
BID	O
take	O
for	O
3	O
months	O
RX	O
*colchicine	O
0.6	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*90	O
Capsule	O
Refills:*0	O
3.	O
GuaiFENesin	O
ER	O
600	O
mg	O
PO	O
Q12H	O
4.	O
LOPERamide	O
2	O
mg	O
PO	O
QID:PRN	O
diarrhea	O
5.	O
Multivitamins	O
W/minerals	O
1	O
TAB	O
PO	O
DAILY	O
6.	O
Torsemide	O
20	O
mg	O
PO	O
DAILY	O
RX	O
*torsemide	O
10	O
mg	O
2	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*2	O
7.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
QHS	O
RX	O
*metoprolol	O
succinate	O
50	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
night	O
Disp	O
#*30	O
Tablet	O
Refills:*2	O
8.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q6H:PRN	O
wheeze	O
9.	O
Apixaban	O
5	O
mg	O
PO	O
BID	O
RX	O
*apixaban	O
[Eliquis]	O
5	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*30	O
Tablet	O
Refills:*2	O
10.	O
Atorvastatin	O
20	O
mg	O
PO	O
QPM	O
11.	O
DICYCLOMine	O
10	O
mg	O
PO	O
BID	O
12.	O
esomeprazole	O
magnesium	O
40	O
mg	O
oral	O
DAILY	O
13.	O
fluticasone-salmeterol	O
500	O
mcg/100	O
mcg	O
inh	O
INHALATION	O
BID	O
14.	O
Metoprolol	O
Succinate	O
XL	O
150	O
mg	O
PO	O
DAILY	O
15.	O
Montelukast	O
10	O
mg	O
PO	O
DAILY	O
16.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
___	O
DAILY	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY	O
=======	O
New	O
Onset	O
Diastolic	O
Heart	O
Failure	O
SECONDARY	O
==========	O
Atrial	O
___	O
pneumonia	B-Lower_respiratory_tract_infection
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
___,	O
___	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
the	O
___	O
___.	O
You	O
were	O
admitted	O
because	O
you	O
had	O
new	O
onset	O
heart	O
failure.	O
It	O
is	O
very	O
important	O
to	O
take	O
all	O
of	O
your	O
heart	O
healthy	O
medications.	O
This	O
includes	O
torsemide,	O
to	O
prevent	O
your	O
lungs	O
from	O
becoming	O
overloaded	O
with	O
fluid,	O
colchicine,	O
to	O
control	O
inflammation	O
of	O
your	O
heart	O
lining,	O
metoprolol,	O
to	O
control	O
your	O
heart	O
rate,	O
and	O
apixaban,	O
to	O
prevent	O
blood	O
clots.	O
At	O
discharge,	O
you	O
weighed	O
143	O
lbs.	O
Please	O
weigh	O
yourself	O
every	O
day	O
in	O
the	O
morning	O
after	O
you	O
go	O
to	O
the	O
bathroom	O
and	O
before	O
you	O
get	O
dressed.	O
If	O
your	O
weight	O
goes	O
up	O
by	O
more	O
than	O
3	O
lbs	O
in	O
1	O
day	O
or	O
more	O
than	O
5	O
lbs	O
in	O
3	O
days,	O
please	O
call	O
your	O
heart	O
doctor	O
or	O
your	O
primary	O
care	O
doctor	O
and	O
alert	O
them	O
to	O
this	O
change.	O
We	O
wish	O
you	O
the	O
best	O
with	O
your	O
health,	O
Your	O
___	O
Cardiac	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

